Vaccines
One in six US parents rejecting standard vaccine schedule: poll
ONE in six American parents has delayed or skipped some or all of the standard childhood vaccines, according to a new Washington Post poll released on Monday.
Drugmakers fall on report US to claim Covid shot killed kids
[WASHINGTON] Vaccine makers’ shares fell after a report that US President Donald Trump health officials plan to link Covid shots to the deaths of around two dozen children in a presentation to adviser...
Florida to scrap all vaccine mandates, West Coast states push back
A TOP health official in Florida on Wednesday vowed to end all vaccine mandates in the state, including school requirements, likening the measure to prevent childhood diseases to “slavery”.
Why bad arguments sound convincing
Ten tricks of logic that underpin vaccine myths deployed by bad-faith actors
Australian biotech giant CSL to spin off vaccine unit Seqirus, cut 15% of workforce
While the Melbourne-based company employs around 32,000 people, no firm number was put on the job cuts
Chinese flu shot maker soars in Hong Kong trading debut
Ab&B is also the last company to go public in the city under listing rules that allowed retail investors to grab as much as half of all allocated shares in an oversubscribed new listing
Sanofi to buy Vicebio for up to US$1.6 billion in vaccine push
The French drugmaker will pay US$1.15 billion upfront with a commitment for potential milestones worth as much as US$450 million
Trump team weighs pulling funds for Moderna bird flu vaccine
The US is in the midst of a record-breaking bird flu outbreak that’s affected dozens of cattle herds along with poultry flocks nationwide, sending egg prices soaring
China’s WuXi Biologics to sell vaccine facility to Merck for US$500 million
WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company seeks to enhance its margins while continuing to navigate geopolitical tensions.
Sanofi profit lifted by early vaccine sales, Dupixent growth
Earnings per share excluding some items reached 2.86 euros in Q3
